Company and Industry Overview * **Company**: Intuitive Surgical, Inc. (NASDAQ: ISRG) * **Industry**: Robotic-Assisted Surgery * **Product**: da Vinci 5, a new generation robotic surgical system Key Points da Vinci 5 Features and Benefits * **Enhanced Precision**: Incorporates next-generation surgeon controllers, patient-side manipulators, and additional sensors for smoother, more precise motion. * **Improved Imaging**: Features the highest quality and most natural 3D surgical imaging system to date, with additional capabilities for future generations of surgical endoscopes and vision software. * **Force Feedback Technology**: Provides real-time force measurement and feedback to surgeons, potentially reducing tissue trauma during surgery. * **Efficient Workflow**: Integrates a high-performance insufflator, next-generation electrosurgical unit, and optimized user interface for improved efficiency. * **Ergonomic Design**: Prioritizes ergonomics for surgeons and care teams, reducing physical strain and improving productivity. * **Increased Computing Power**: Offers 10,000x the computing power of previous generations, supporting advanced digital experiences and future features. Regulatory Clearance and Indications * FDA cleared da Vinci 5 for the same indications as da Vinci Xi, except for cardiac and pediatric indications. * Optional Force Feedback needle driver contraindicated for use in suturing in hysterectomy and myomectomy procedures. Financial Impact * Gross system ASPs for da Vinci 5 expected to be approximately 30% higher than Xi. * Total acquisition cost for da Vinci 5 approximately 15% higher than Xi when considering the full stack of integrated items. * Gross margins for da Vinci 5 expected to be significantly below the corporate average initially, with plans to improve over time. Launch Strategy * Phased launch in the U.S. starting in 2024, with a focus on customers who collaborated during development and those with mature robotic programs. * Limited launch phase expected to continue into 2025, with a focus on optimizing manufacturing and supply chains. * Broad launch expected in the first several years of the trading cycle. Competitive Positioning * da Vinci 5 will be positioned as the top product in Intuitive Surgical's portfolio, alongside da Vinci Xi, da Vinci X, and da Vinci SP. * da Vinci Xi will continue to be offered as a highly capable system for cost-sensitive markets and other sites of care. Future Outlook * da Vinci 5 expected to improve interoperative efficiency, increase procedure throughput, and potentially lower the total cost to treat per patient episode compared to Xi. * Intuitive Surgical plans to pursue additional indications for da Vinci 5 in future years. * da Vinci 5 expected to drive robotic surgery adoption and contribute to the evolution of surgical practice.

Intuitive Surgical (ISRG) recently announced the FDA 510(k) clearance for its da Vinci 5 fifth-generation multiport robotic system.The newest member of the da Vinci family is da Vinci 5, which also comprises the single-port da Vinci SP and the multiport da Vinci X and Xi systems. They provide hospitals and surgeons with an array of Intuitive Surgical's extremely competent and tested solutions.With more than 7 million surgeries performed to date, surgeons and care teams worldwide have utilized Xi's extremely ...

Intuitive Surgical (NASDAQ:ISRG) stock is getting a boost on Friday as investors celebrate approval of da Vinci 5 by the Food and Drug Administration (FDA).Da Vinci 5 is the next generation of Intuitive Surgical’s multiport robotic system that has been used in more than 7 million procedures. The newest version brings with it increased performance, an enhanced 3D imaging system and new Force Feedback technology.Myriam J. Curet, M.D., Chief Medical Officer of Intuitive Surgical, said the following about the d ...

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company's next-generation multiport robotic system. "We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5," said Gary Guthart, CEO. "Intuitive is committed to meaningful improvements i ...

If the market’s dramatic shifts this year have left you feeling dizzy, you’re not alone – but blue-chip stocks might be the anchor you need to regain stability. Amidst the current rally (bubble?), we’ve seen stocks rise, plummet, and rise again, pushing investors toward small-caps, tech, and growth stocks. But, while profitable thus far, that might be the wrong move, while blue-chip represents foundational stability sorely lacking within many portfolios.The economic landscape remains uncertain, far from a c ...

In the latest market close, Intuitive Surgical, Inc. (ISRG) reached $382.99, with a -1.65% movement compared to the previous day. The stock fell short of the S&P 500, which registered a loss of 0.19% for the day. At the same time, the Dow added 0.1%, and the tech-heavy Nasdaq lost 0.54%.The company's shares have seen an increase of 2.77% over the last month, not keeping up with the Medical sector's gain of 2.91% and the S&P 500's gain of 3.18%.Market participants will be closely following the financial resu ...

With technology evolving at a break-neck pace, robotics emerges at the forefront of innovation, offering transformative potential across many sectors from manufacturing to healthcare. Hence, for those with a forward-thinking approach, betting on the top robotics stocks to buy presents itself as a lucrative long-term investment realm.Moreover, Precedent Research is incredibly optimistic about the sector’s growth runway, forecasting a meteoric rise to roughly $283.19 billion by 2032, supported by a robust CAG ...

Intuitive Surgical, Inc. (ISRG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this company have returned -0.6% over the past month versus the Zacks S&P 500 composite's +2.9% change. The Zacks Medical - Instruments industry, to which Intuitive Surgical, Inc. belongs, has gained 3.6% over this period. Now the key question is: Where could the stock be head ...

Intuitive Surgical, Inc. (ISRG) closed the latest trading day at $400.59, indicating a +0.68% change from the previous session's end. The stock's change was more than the S&P 500's daily loss of 0.12%. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq depreciated by 0.41%.Coming into today, shares of the company had gained 3.68% in the past month. In that same time, the Medical sector gained 3.58%, while the S&P 500 gained 4.83%.Market participants will be closely following the financ ...

As you may have learned recently, the "Magnificent Seven" is a group of powerhouse stocks including Nvidia, Apple, and Microsoft, most of which have benefited significantly from the enthusiasm surrounding their artificial intelligence (AI) efforts. But which would be the equivalent businesses if the same concept were applied to the healthcare sector rather than the technology sector?As it turns out, there are only four stocks that have the right combination of ongoing growth and market-outperforming returns ...